Industry
47d agoInsilico Medicine and CMS Target CNS Diseases
Insilico Medicine and China Medical System expanded their partnership to accelerate R&D for central nervous system diseases. The collaboration leverages generative AI to identify novel drug targets and optimize lead compounds. This deal streamlines the discovery pipeline for complex neurological conditions.
The Signal
Practitioners can expect faster iteration cycles in AI-driven biotech drug development.